Singapore: Eisai suspended sales of its epilepsy drug Fycompa (perampanel) in Germany due to unfavorable conditions set ...
Singapore: Daiichi Sankyo Company and ArQule announced the top-line results of a randomized phase II signal generation ...
Singapore: Takeda Pharmaceutical International completed the construction of its pharmaceutical manufacturing facility a...
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...
Singapore: A*STAR's Immunology Network (SIgN), Singapore, and Immunology Frontier Research Center (IFReC), Osaka Univers...
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...
Singapore: Takeda Pharmaceutical, which has completed the acquisition of URL Pharma, will immediately assume responsibil...
Singapore: Shionogi, US, received US FDA approval for Osphena (ospemifene) tablets for the treatment of moderate to se...
Singapore: Toshiba Medical Systems, part of Japan-based Toshiba Corporation, has entered into a partnership with Manches...
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...
Singapore: Takeda today announced the launch of a new expert report on COPD on the occasion of the 2012 European Respira...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
The Asian business strategy of multinational pharmaceutical companies in terms of resource reallocation and investment w...
Singapore: Western Europe, the US and Japan will continue to account for almost 60 percent of the total market, accordin...
Singapore: This year, the Tenth Takamine Memorial Daiichi Sankyo Prize will be awarded to Dr Takeshi Iwatsubo, professor...
Singapore: Swiss company Covagen has entered into a strategic research collaboration and license agreement with Japanese...
Singapore: Daiichi Sankyo has announced data from the PRASFIT-ACS study, a double-blind randomized phase III trial compa...
